Champions Oncology (CSBR) Return on Capital Employed (2016 - 2025)
Historic Return on Capital Employed for Champions Oncology (CSBR) over the last 15 years, with Q4 2025 value amounting to 0.26%.
- Champions Oncology's Return on Capital Employed rose 3900.0% to 0.26% in Q4 2025 from the same period last year, while for Oct 2025 it was 0.26%, marking a year-over-year increase of 3900.0%. This contributed to the annual value of 0.85% for FY2025, which is 16900.0% up from last year.
- Champions Oncology's Return on Capital Employed amounted to 0.26% in Q4 2025, which was up 3900.0% from 0.31% recorded in Q3 2025.
- In the past 5 years, Champions Oncology's Return on Capital Employed ranged from a high of 0.78% in Q1 2025 and a low of 1.72% during Q1 2024
- Over the past 5 years, Champions Oncology's median Return on Capital Employed value was 0.01% (recorded in 2021), while the average stood at 0.21%.
- Per our database at Business Quant, Champions Oncology's Return on Capital Employed tumbled by -15300bps in 2024 and then soared by 25000bps in 2025.
- Champions Oncology's Return on Capital Employed (Quarter) stood at 0.03% in 2021, then crashed by -44bps to 0.01% in 2022, then tumbled by -8104bps to 1.16% in 2023, then skyrocketed by 89bps to 0.13% in 2024, then soared by 307bps to 0.26% in 2025.
- Its Return on Capital Employed was 0.26% in Q4 2025, compared to 0.31% in Q3 2025 and 0.6% in Q2 2025.